Latest publications

Fibroblast mitochondria in idiopathic Parkinson's disease display morphological changes and enhanced resistance to depolarization.

  • Transversal Translational Medicine
January 31, 2020
2020 Jan. Sci Rep.10(1):1569.
By:
  • Antony PMA
  • Kondratyeva O
  • Mommaerts K
  • Ostaszewski M
  • Sokolowska K
  • Baumuratov AS
  • Longhino L
  • Poulain JF
  • Grossmann D
  • Balling R
  • Kruger R
  • Diederich NJ.

Quality control strategy for CRISPR-Cas9-based gene editing complicated by a pseudogene.

  • Transversal Translational Medicine
January 08, 2020
2020 Jan. Front Genet.10:1297.
By:
  • Hanss Z
  • Boussaad I
  • Jarazo J
  • Schwamborn JC
  • Kruger R.

Variants in Miro1 cause alterations of ER-Mitochondria contact sites in fibroblasts from Parkinson’s disease patients.

  • Transversal Translational Medicine
December 16, 2019
2019 Dec. J Clin Med.8(12):2226.
By:
  • Berenguer-Escuder C
  • Grossmann D
  • Massart F
  • Antony P
  • Burbulla LF
  • Glaab E
  • Imhoff S
  • Trinh J
  • Seibler P
  • Grunewald A
  • Kruger R.

Gene-environment interaction and Mendelian randomisation.

  • Transversal Translational Medicine
December 01, 2019
2019 Dec. Rev Neurol.175(10):597-603. Epub 2019 Sep 19.
By:
  • Kolber P
  • Kruger R.

Multilingual validation of the first French version of Munich Dysphagia Test–Parkinson’s Disease (MDT-PD) in the Luxembourg Parkinson’s Study.

  • Transversal Translational Medicine
  • Competence Center for Methodology and Statistics
October 22, 2019
2019 Oct. Front Neurol.10:1180. Accepted.
By:
  • Simons JA
  • Vaillant M
  • Hipp G
  • Pavelka L
  • Stute L
  • Pauly C
  • Kruger R.